NDC 17088-0354 – Canakinumab
Canakinumab 150 mg/mL · Injection, Solution
Product NDC17088-0354
Product details
- Brand name
- Canakinumab
- Generic name
- Canakinumab
- Labeler
- Novartis Pharma Stein AG
- Dosage form
- Injection, Solution
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketed since
- December 22, 2016
- Listing expires
- December 31, 2027
Active ingredients
- Canakinumab 150 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 17088-0354-1 | 1 mL in 1 VIAL, SINGLE-USE (17088-0354-1) |